A CRYPTOLEPIS SANGUINOLENTA-BASED PREPARATION REDUCED HOSPITAL STAY AND MORTALITY OF COVID-19 PATIENTS DURING THE PANDEMI
African Journal of Traditional, Complementary and Alternative Medicines · 29.09.2025 · 20 (1) · 1-11
DOI: 10.21010/ajtcamv21i1.1 ↗Kurz gefasst
Fachartikel in der Zeitschrift African Journal of Traditional, Complementary and Alternative Medicines, online erschienen am 29.08.2025. Verfasst von Mohamed MUTOCHELUH und 13 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background:In 2020, the World Health Organization urged nations to take domestic steps to curb the spread and contain the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) pandemic, also referred to as coronavirus disease 2019 (COVID-19). In the meantime, there was growing clinical evidence that reported favourable effects of using herbal medicine in managingCOVID-19. We, therefore, repurposed Nibima (a Cryptolepis sanguinolenta-based herbal preparation) as an adjunct to conventional therapy for COVID-19. This was premised on our previous in vitroinvestigations that showed that Nibima has both antiviral and anti-inflammatory activities. Materials and Methods:This trial (FDA/CT/11) was an open-label, randomised controlled phase II pilot study, which was conducted from March 2021 to October 2022 among hospitalised COVID-19 patients in the Ashanti Region of Ghana. Participants were either randomised to aqua(water)or Nibima,the investigational product as adjunct to COVID therapy. Results:Nibima was well tolerated by the study participants, and the patients who were administered that together with the standard COVID-19 therapy had rapid clinical recovery compared to those taking aqua and the standardorconventional COVID-19 therapy. The evidence obtained provides a strong basis for future studies with large numbers of hospitalised patients with COVID-19 and other viral respiratory infections. Article HistoryReceived: June 11th2024Revised Received: April 13th2025 Accepted:April 14th2025Published Online: Aug. 29th2025 2Conclusion: Though COVID-19 is no longer a pandemic, it is still a public health challenge. We recommend that Nibima be further investigated for its broad-spectrum antiviral and immunomodulatory activities against SARS-COV-2 and other viral infections in preparedness for the re-emergence of future pandemics
Zitieren
APA
MUTOCHELUH, M., ANSAH, C., BUABENG, K. O., TWUMASI-ANKRAH, S., DOMFEH, S. A., OWUSU, M., OWUSU-ANSAH, M., BORQUAYE, L. S., ADEI, E., DUAH, C., BOAMAH, D., BOAKYE-YIADOM, M., BARIMAH, K. B., & OWUSU-DABO, E. (2025). A CRYPTOLEPIS SANGUINOLENTA-BASED PREPARATION REDUCED HOSPITAL STAY AND MORTALITY OF COVID-19 PATIENTS DURING THE PANDEMI. African Journal of Traditional, Complementary and Alternative Medicines, 20(1), 1-11. https://doi.org/10.21010/ajtcamv21i1.1
Vancouver
MUTOCHELUH M, ANSAH C, BUABENG KO, TWUMASI-ANKRAH S, DOMFEH SA, OWUSU M, et al. A CRYPTOLEPIS SANGUINOLENTA-BASED PREPARATION REDUCED HOSPITAL STAY AND MORTALITY OF COVID-19 PATIENTS DURING THE PANDEMI. African Journal of Traditional, Complementary and Alternative Medicines. 2025;20(1):1-11. doi:10.21010/ajtcamv21i1.1
BibTeX
@article{MUTOCHELUH2025,
author = {MUTOCHELUH, Mohamed and ANSAH, Charles and BUABENG, Kwame Ohene and TWUMASI-ANKRAH, Sampson and DOMFEH, Seth Agyei and OWUSU, Michael and OWUSU-ANSAH, Michae and BORQUAYE, Lawrence Sheringha and ADEI, Evans and DUAH, Christiana and BOAMAH, Daniel and BOAKYE-YIADOM, Mavis and BARIMAH, Kofi Bobi and OWUSU-DABO, Ellis},
title = {A CRYPTOLEPIS SANGUINOLENTA-BASED PREPARATION REDUCED HOSPITAL STAY AND MORTALITY OF COVID-19 PATIENTS DURING THE PANDEMI},
journal = {African Journal of Traditional, Complementary and Alternative Medicines},
year = {2025},
volume = {20},
number = {1},
pages = {1--11},
doi = {10.21010/ajtcamv21i1.1}
}
EUVIMED